Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis
- PMID: 28521842
- PMCID: PMC5437521
- DOI: 10.1186/s12957-017-1163-y
Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis
Abstract
Background: Recent studies have indicated an association between hypoxia inducible factor-1 alpha (HIF-1α) expression and poor prognosis in patients with oral squamous cell carcinoma (OSCC); however, definitive evidence of this association is yet to be obtained. We performed a meta-analysis to evaluate the association of HIF-1α expression with clinicopathological characteristics and overall survival (OS) of patients with OSCC.
Methods: A literature search for relevant studies published in English language as of February 05, 2016, was performed on PubMed, Web of Science, and EMBASE databases. Eighteen studies with a combined study population of 1474 patients with OSCC are included in the meta-analysis. Odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI) was calculated using random-effects model or fixed-effects model.
Results: HIF-1α overexpression was significantly associated with larger tumor size (OR = 2.28, 95% CI = 1.49-3.50, P = 0.017), advanced TNM stage (OR = 2.29, 95% CI = 1.50-3.49, P = 0.158), and lymph node metastasis (OR = 2.05, 95% CI = 1.19-3.53, P < 0.001), but not with poor differentiation (OR = 1.21, 95% CI = 0.55-2.64, P = 0.024). These results demonstrated an association between HIF-1α expression and biological behavior of OSCC. On pooled analyses, high expression of HIF-1α was associated with worse OS (HR = 1.70, 95% CI = 1.10-2.61, P < 0.001). On subgroup analyses, overexpression of HIF-1α was significantly associated with poor prognosis in Asian population (HR = 2.33, 95% CI = 1.72-3.15, P = 0.862).
Conclusions: Our findings demonstrate an association of HIF-1α overexpression with tumor size, tumor stage, lymph node metastasis, and overall survival. HIF-1α could be an independent prognostic marker in patients with OSCC.
Keywords: Hypoxia inducible factor-1α; Meta-analysis; Oral squamous cell carcinoma; Prognosis.
Figures
Comment in
-
Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study.World J Surg Oncol. 2018 Jun 18;16(1):111. doi: 10.1186/s12957-018-1408-4. World J Surg Oncol. 2018. PMID: 29914529 Free PMC article.
References
-
- Noguti J, De Moura CF, De Jesus GP, et al. Metastasis from oral cancer: an overview. Cancer Genomics Proteomics. 2012;9:329–35. - PubMed
-
- DE Lima PO, Jorge CC, Oliveira DT, et al. Hypoxic condition and prognosis in oral squamous cell carcinoma. Anticancer Res. 2014;34:605-12. - PubMed
-
- Zhong LP, Zhang CP, Ren GX, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013;31:744–51. doi: 10.1200/JCO.2012.43.8820. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
